Inspire Medical Systems Inc (INSP) 13F Ownership Report (Q2 2026)

INSP ranks #2288 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

INSP is a disclosed holding of Cliff Asness (AQR Capital Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

278 institutions disclose a position in INSP, but none treat it as a major bet — even Soleus Capital Management, L.P., its most concentrated holder, allocates just 3.0% of its own portfolio to it.

Assenagon Asset Management S.A. has added to its INSP position for two straight quarters, increasing it by $17.8M to reach $44.6M today.

State of Alaska, Department of Revenue has trimmed its INSP position for two straight quarters, cutting it by $329.0K while still holding $418.0K.

INSP is down 1.9% today, but institutions show net buying of $358.5M this quarter — a divergence between today's price move and the underlying institutional flow.

INSP posted net income of $135.0M over the trailing twelve months, and currently trades at a P/E of 15.2.

• Profitable — net income of $135.0M over the trailing twelve months
• Revenue grew 4.3% year over year
• Net income improved year over year, from $53.1M to $135.0M
• Generated $117.0M in positive operating cash flow
• Current ratio of 6.08x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.16x equity — within a conventional range